{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:11:19Z","timestamp":1783930279754,"version":"3.55.0"},"reference-count":36,"publisher":"Tsinghua University Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study evaluated the impact of the Medicine IN Geriatric (MINE) application, which integrates the Integrated Medicine Management (IMM) model and STOPP\/START criteria, on improving prescribing practices in elderly patients with congestive heart failure (CHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-phase study was conducted: validation of the IMM model and its implementation via the MINE app. A quasi-experimental pretest-posttest control group design was used in a hospital in East Kalimantan, Indonesia. Patients aged 60\u201379 years were randomly assigned to the intervention or control group. The intervention group received IMM-based pharmaceutical services, including medication reconciliation, repeated medication reviews, and individualized discharge counseling. The outcomes assessed included polypharmacy rates, potentially inappropriate medications (PIMs), potential prescribing omissions (PPOs), and health-related quality of life, using the EQ-5D-5L and EQ-VAS tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Expert validation showed high content validity, with I-CVI \u2265 0.86 and S-CVI = 0.94. During implementation, the use of antiplatelets, statins, angiotensin converting enzyme inhibitors (ACEI), and angiotensin receptor \u03b2-blockers (ARB) declined from admission to discharge. PIMs, such as beta-blockers in patients with conduction disorders and ACE-I\/ARBs in those with hyperkalemia, also decreased. The intervention group\u2019s EQ-5D-5L scores improved from 0.552 to 0.664, whereas the control group's scores declined slightly. EQ-VAS scores also increased significantly in the intervention group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The MINE-based IMM intervention effectively reduced inappropriate prescribing and enhanced the quality of life in elderly patients with CHF. This technology-enabled multidisciplinary approach supports safer prescribing in geriatric care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.26599\/1671-5411.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:46:37Z","timestamp":1783928797000},"page":"296-308","source":"Crossref","is-referenced-by-count":0,"title":["Integrated drug management for elderly patients with congestive heart failure: enhancing medication accuracy using the MINE (Medicine IN gEriatric) application"],"prefix":"10.26599","volume":"23","author":[{"given":"Welinda Dyah","family":"Ayu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umi","family":"Athiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carta Agrawanto","family":"Gunawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elida","family":"Zairina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/eurjhf\/hft064","article-title":"The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden","volume":"15","author":"R Zarrinkoub","year":"2013","unstructured":"R Zarrinkoub. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. 2013, 15: 995-1002.","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"N Conrad","year":"2018","unstructured":"N Conrad. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. 2018, 391: 572-580.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.hfc.2017.02.001","article-title":"Epidemiology, pathophysiology, and prognosis of Heart failure in older adults","volume":"13","author":"K Dharmarajan","year":"2017","unstructured":"K Dharmarajan. Epidemiology, pathophysiology, and prognosis of Heart failure in older adults. 2017, 13: 417-426.","journal-title":"Heart Fail Clin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/CLEP.S170873","article-title":"Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden","volume":"11","author":"K Lindmark","year":"2019","unstructured":"K Lindmark. Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden. 2019, 11: 231-244.","journal-title":"Clin Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"EES van Riet","year":"2016","unstructured":"EES van Riet. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. 2016, 18: 242-252.","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/ehf2.12773","article-title":"Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016","volume":"7","author":"KM \u00d8degaard","year":"2020","unstructured":"KM \u00d8degaard. Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016. 2020, 7: 1917-1926.","journal-title":"ESC Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12875-017-0642-0","article-title":"Current and future perspectives on the management of polypharmacy","volume":"18","author":"M Molokhia","year":"2017","unstructured":"M Molokhia. Current and future perspectives on the management of polypharmacy. 2017, 18: 70.","journal-title":"BMC FAM Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1067\/mem.2001.119456","article-title":"Polypharmacy, adverse drug-related events, and potential adverse drug interactions in older patients presenting to an emergency department","volume":"38","author":"CM Hohl","year":"2001","unstructured":"CM Hohl. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in older patients presenting to an emergency department. 2001, 38: 666-671.","journal-title":"Ann Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","article-title":"Anticholinergic drugs and physical function among frail older population","volume":"81","author":"F Landi","year":"2007","unstructured":"F Landi. Anticholinergic drugs and physical function among frail older population. 2007, 81: 235-241.","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"AH Lavan","year":"2016","unstructured":"AH Lavan. Predicting risk of adverse drug reactions in older adults. 2016, 7: 11-22.","journal-title":"Ther Adv Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/11599430-000000000-00000","article-title":"Adverse drug reaction\u2014Related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands","volume":"29","author":"R Ruiter","year":"2012","unstructured":"R Ruiter. Adverse drug reaction\u2014Related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. 2012, 29: 225-232.","journal-title":"Drugs Aging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s40520-019-01304-5","article-title":"Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network","volume":"33","author":"G Sferrazza","year":"2021","unstructured":"G Sferrazza. Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network. 2021, 33: 1683-1687.","journal-title":"Aging Clin Exp Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/1475-6773.12562","article-title":"Determinants of potentially inappropriate medication use among community-dwelling older adults","volume":"52","author":"GE Miller","year":"2017","unstructured":"GE Miller. Determinants of potentially inappropriate medication use among community-dwelling older adults. 2017, 52: 1534-1549.","journal-title":"Health Serv Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation","volume":"46","author":"P Gallagher","year":"2008","unstructured":"P Gallagher. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. 2008, 46: 72-83.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2042098619829431","article-title":"Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences","volume":"10","author":"DF Curtin","year":"2019","unstructured":"DF Curtin. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. 2019, 10: 1-10.","journal-title":"Ther Adv Drug Saf"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jcpt.12059","article-title":"Application of the STOPP\/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact","volume":"38","author":"B Hill-Taylor","year":"2013","unstructured":"B Hill-Taylor. Application of the STOPP\/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. 2013, 38: 360-372.","journal-title":"J Clin Pharm Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","article-title":"Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review","volume":"71","author":"E Tommelein","year":"2015","unstructured":"E Tommelein. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. 2015, 71: 1415-1427.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1365-2753.2006.00753.x","article-title":"An innovative approach to integrated medicines management","volume":"13","author":"C Scullin","year":"2007","unstructured":"C Scullin. An innovative approach to integrated medicines management. 2007, 13: 781-788.","journal-title":"J Eval Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the EQ-5D-5L","volume":"20","author":"M Herdman","year":"2011","unstructured":"M Herdman. Development and preliminary testing of the EQ-5D-5L. 2011, 20: 1727-1736.","journal-title":"Qual Life Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"A Iorga","year":"2017","unstructured":"A Iorga. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. 2017, 8: 33.","journal-title":"Biol Sex Differ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/eurjhf\/hft028","article-title":"Heart failure in elderly patients: distinctive features and unresolved issues","volume":"15","author":"V Lazzarini","year":"2013","unstructured":"V Lazzarini. Heart failure in elderly patients: distinctive features and unresolved issues. 2013, 15: 717-723.","journal-title":"Eur J Heart Fail"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e010989","DOI":"10.1136\/bmjopen-2015-010989","article-title":"Defining polypharmacy in the elderly: a systematic review protocol","volume":"6","author":"SS Mortazavi","year":"2016","unstructured":"SS Mortazavi. Defining polypharmacy in the elderly: a systematic review protocol. 2016, 6: e010989.","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2147\/CIA.S107394","article-title":"Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP\/START criteria: a cross-sectional study","volume":"11","author":"H Getachew","year":"2016","unstructured":"H Getachew. Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP\/START criteria: a cross-sectional study. 2016, 11: 819-827.","journal-title":"Clin Interv Aging"},{"key":"ref28","first-page":"1098","article-title":"Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis","volume":"72","author":"A Page","year":"2024","unstructured":"A Page. Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis. 2024, 72: 1098-1110.","journal-title":"J Am Geriatr Soc"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"D O\u2019Mahony. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. 2015, 44: 213-218.","journal-title":"Age Ageing"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"71","author":"American Geriatrics Society Beers Criteria Update Expert Panel","year":"2023","unstructured":"American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated Beers Criteria for potentially inappropriate medication use in older adults. 2023, 71: 2052-2081.","journal-title":"J Am Geriatr Soc"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/CLEP.S153458","article-title":"The epidemiology of polypharmacy in older adults: register-based prospective cohort study","volume":"10","author":"L Morin","year":"2018","unstructured":"L Morin. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. 2018, 10: 289-298.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jcpt.13758","article-title":"Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam","volume":"47","author":"H Phan","year":"2022","unstructured":"H Phan. Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam. 2022, 47(1): 113-121.","journal-title":"J Clin Pharm Ther."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00228-010-0982-3","article-title":"Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits","volume":"67","author":"LM Hellstr\u00f6m","year":"2011","unstructured":"LM Hellstr\u00f6m. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. 2011, 67: 741-752.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3349\/ymj.2022.0620","article-title":"Effect of pharmacist-led intervention in elderly patients through a comprehensive medication reconciliation: a randomized clinical trial","volume":"64","author":"S Lee","year":"2023","unstructured":"S Lee. Effect of pharmacist-led intervention in elderly patients through a comprehensive medication reconciliation: a randomized clinical trial. 2023, 64: 336-343.","journal-title":"Yonsei Med J."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"IA Scott","year":"2015","unstructured":"IA Scott. Reducing inappropriate polypharmacy: the process of deprescribing. 2015, 175: 827-834.","journal-title":"JAMA Internal Medicine"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/1474515117702021","article-title":"Self-care and health-related quality of life in chronic heart failure: A longitudinal analysis","volume":"16","author":"D Kessing","year":"2017","unstructured":"D Kessing. Self-care and health-related quality of life in chronic heart failure: A longitudinal analysis. 2017, 16: 605-613.","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/0269215512474030","article-title":"A qualitative study exploring patients\u2019 and carers\u2019 experiences of early supported discharge services after stroke","volume":"27","author":"CS Cobley","year":"2013","unstructured":"CS Cobley. A qualitative study exploring patients\u2019 and carers\u2019 experiences of early supported discharge services after stroke. 2013, 27: 750-757.","journal-title":"Clin Rehabil"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1365-2702.2008.02600.x","article-title":"Discharge planning of stroke patients: the relatives\u2019 perceptions of participation","volume":"18","author":"AH Almborg","year":"2009","unstructured":"AH Almborg. Discharge planning of stroke patients: the relatives\u2019 perceptions of participation. 2009, 18: 857-865.","journal-title":"J Clin Nurs"},{"issue":"9","key":"ref40","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archinternmed.2009.71","article-title":"A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial","volume":"169","author":"U Gillespie","year":"2009","unstructured":"U Gillespie. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. 2009, 169(9): 894-900.","journal-title":"Arch Intern Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e010003","DOI":"10.1136\/bmjopen-2015-010003","article-title":"Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis","volume":"6","author":"AB Mekonnen","year":"2016","unstructured":"AB Mekonnen. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. 2016, 6: e010003.","journal-title":"BMJ Open"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:46:38Z","timestamp":1783928798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.05.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.05.002","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}